The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly ...
Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...
ZME Science on MSN
Meet Stephen Quake: The Scientist Who Treats Biology like Physics and Turned Life Into Data
Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.
Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...
Once largely overlooked, jaboticaba is now catching scientists’ attention as they study how the fruit produces its wide mix ...
Zacks.com on MSN
Three Genomics Stocks Worth Tracking This Year
Genomics advances are reshaping drug discovery, with Pacific Biosciences of California emerging as a key player in next-gen ...
Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals are pleased to announce they are receiving advisory ...
Researchers analyzed DNA methylation in human skeletal muscle and identified age-linked epigenetic markers that enable highly ...
Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...
Impacts of biological amendments, including waste-derived amendments that underpin soil health and agricultural ...
EDINBURGH, Scotland, TORONTO and EDMONTON, AB, Jan. 6, 2026 /PRNewswire/ -- Chromatin Bioscience, Mediphage Bioceuticals, and Entos Pharmaceuticals are pleased to announce they are receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback